Mutz Christopher sold ANIP
March 2, 2026 · Form 4 insider transaction
Mutz Christopher sold 417 shares of ANI Pharmaceuticals, Inc. at $74.00 per share, a transaction worth $30.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
417
Price
$74.00
Total value
$30.9K
InsiderMutz Christopher
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after103,508
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.